Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura E Warren, M.D.

Concepts (138)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms920231502.420 Why?
Carcinoma, Intraductal, Noninfiltrating520249201.660 Why?
Breast Neoplasms242024210561.280 Why?
Mastectomy, Segmental820219641.060 Why?
Neoplasm Recurrence, Local7202493730.800 Why?
Central Nervous System Neoplasms220229160.800 Why?
Radiotherapy, Adjuvant9202417760.700 Why?
Lymphatic Irradiation420181100.700 Why?
Phyllodes Tumor12020540.670 Why?
Radiation Oncology420245690.600 Why?
Lymphedema420185250.510 Why?
Clinical Trials, Phase II as Topic120166390.430 Why?
Telephone120166270.400 Why?
Premenopause1201610370.390 Why?
Carcinoma, Ductal, Breast2202010830.380 Why?
Sentinel Lymph Node Biopsy220187280.370 Why?
Breast Diseases120144360.350 Why?
Patient Education as Topic3202423340.320 Why?
Lymph Node Excision6201812590.300 Why?
Mastectomy5202418470.290 Why?
Carcinoma2201723120.280 Why?
Consensus1201632020.260 Why?
Axilla420186150.250 Why?
Evidence-Based Medicine1201636850.220 Why?
Body Mass Index42020130390.200 Why?
Patient Participation1201214550.200 Why?
Learning1201217550.200 Why?
Receptor, erbB-26202325930.190 Why?
Mastectomy, Modified Radical32017590.190 Why?
Quality of Health Care1201643000.180 Why?
Female3320243961120.180 Why?
Fluorodeoxyglucose F182202020240.180 Why?
Neoplasm Staging62023112060.150 Why?
Decision Making1201239650.150 Why?
Aged, 80 and over102019594890.140 Why?
Brain Neoplasms2201790710.140 Why?
Receptors, Progesterone3202011530.140 Why?
Retrospective Studies122022815140.140 Why?
Disease-Free Survival3201668320.140 Why?
Chemotherapy, Adjuvant4202335370.140 Why?
Humans3620247659680.130 Why?
Ideal Body Weight12016270.130 Why?
Therapeutic Equipoise12016290.130 Why?
Cranial Irradiation120193850.130 Why?
Middle Aged1920242230090.130 Why?
Carcinoma, Lobular120204710.130 Why?
Central Nervous System1202213410.120 Why?
Cisplatin1202116580.120 Why?
Patient Care Planning120209060.120 Why?
Obesity12016130760.110 Why?
Mammaplasty2202412640.110 Why?
Incidence42022214800.110 Why?
Immunocompromised Host120198660.110 Why?
Lymphatic Metastasis3201628870.110 Why?
Combined Modality Therapy3202185290.100 Why?
Thinness120164820.100 Why?
Aged1420241711170.100 Why?
Efficiency120164800.100 Why?
Patient Care Team1202425170.100 Why?
Muscle Fibers, Skeletal120165520.100 Why?
Radiopharmaceuticals2202026990.100 Why?
Radiation Injuries1201911810.090 Why?
Follow-Up Studies52020391930.090 Why?
Estrogen Receptor alpha120155780.090 Why?
Adult1420242230440.090 Why?
Reimbursement Mechanisms120166720.090 Why?
Meningeal Neoplasms1201912520.080 Why?
Artificial Intelligence1202426590.080 Why?
Radiosurgery1201913280.080 Why?
Patient Selection1202142550.080 Why?
Arm120125890.080 Why?
Pluripotent Stem Cells120168070.080 Why?
Analysis of Variance2201562030.080 Why?
Treatment Failure1201526520.080 Why?
Treatment Outcome52024651880.070 Why?
Kaplan-Meier Estimate2201564990.070 Why?
Postmenopause1201625150.070 Why?
Lymph Nodes2201634540.070 Why?
Risk Factors52020748400.070 Why?
Clinical Clerkship120115680.060 Why?
Overweight1201624440.060 Why?
Qualitative Research1201631390.060 Why?
Neoadjuvant Therapy3202328950.060 Why?
Survival Rate22017127950.060 Why?
Educational Measurement1201112600.060 Why?
Young Adult52021598890.060 Why?
Prognosis32019299220.050 Why?
Carcinoma, Squamous Cell1201940440.050 Why?
Antineoplastic Combined Chemotherapy Protocols32023118680.050 Why?
Insulin Resistance1201639850.050 Why?
Cognition1201970490.050 Why?
Breast Implants120244110.040 Why?
Time Factors32018400650.040 Why?
Receptors, Estrogen2202022420.040 Why?
General Surgery1201117220.040 Why?
Prospective Studies42021548020.040 Why?
Skin Neoplasms1201958490.040 Why?
Education, Medical, Graduate1201124180.040 Why?
Comprehension120246380.040 Why?
Health Literacy120244640.040 Why?
Maximum Tolerated Dose120218980.040 Why?
Proportional Hazards Models32018125090.040 Why?
Disease Progression12015136320.040 Why?
Randomized Controlled Trials as Topic12014103830.040 Why?
Tomography, X-Ray Computed12020206590.030 Why?
Risk2201895910.030 Why?
Patient Preference120249520.030 Why?
Survival Analysis22018100700.030 Why?
Reactive Oxygen Species1202321400.030 Why?
Anthracyclines120172840.030 Why?
Risk Assessment12016242820.030 Why?
Taxoids120176650.030 Why?
Hormones120178630.030 Why?
Neoplasm, Residual1201710090.020 Why?
Radiotherapy Dosage1201928650.020 Why?
Guidelines as Topic1201813940.020 Why?
Cyclophosphamide1201722280.020 Why?
Postoperative Complications12012157470.020 Why?
Immunologic Factors1201915870.020 Why?
Quality of Life22024134620.020 Why?
Hematologic Neoplasms1201919270.020 Why?
Regression Analysis1201563220.020 Why?
Multivariate Analysis12019120560.020 Why?
Odds Ratio1201796490.010 Why?
Diagnosis, Differential12020129760.010 Why?
Pandemics1202387030.010 Why?
United States22023729030.010 Why?
Case-Control Studies12020222230.010 Why?
Insulin1201665990.010 Why?
Feasibility Studies1201153020.010 Why?
Cell Differentiation12016116410.010 Why?
Male320243636980.010 Why?
Infant12016363860.010 Why?
Child, Preschool12016425000.010 Why?
Signal Transduction12016236010.010 Why?
HIV Infections12019175330.010 Why?
Diabetes Mellitus, Type 212016122400.010 Why?
Adolescent12017888350.000 Why?
Warren's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (138)
Explore
_
Co-Authors (62)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.